PDCI Market Access | Request for Reconsideration

Tel: (613) 742-8225

/

info@pdci.ca

Newsletter Sign-Up
Login to PDCI Services
Contact Us

Home
About Us
Services
- Case Studies
News & Events
Resources
Consultation Responses
Blog
Publications

Request for Reconsideration

Home Request for Reconsideration

Request-for-Reconsideration-To-CADTH Download

July 2, 2020 / CADTH, What's New

Search

Categories

Categories

Recent Posts

PDCI Strengthens Leadership to Enhance Real World Evidence (RWE) Services and Strategic Consulting Capabilities
pCPA Appoints Douglas Clark as its First CEO
PCPA Seeks Stakeholder Input On Its Proposed Process To Implement CADTH Time-Limited Recommendations
Updates on PMPRB Activities in June 2023 NEWSletter
CADTH Announces Changes to Reimbursement Reviews Process & Fee Schedule Update

Newsletter Sign Up

TargetPharma is PDCI Market Access’ Free E-mail Newsletter

TargetPharma

TargetPharma is a free e-mail newsletter featuring the latest developments on policy, pricing and reimbursement in the pharmaceutical industry at the provincial and federal levels. Subscribe to stay informed on relevant activities within the PMPRB, the pCPA, CADTH (CDR and pCODR), Health Canada, and emerging issues and trends within Canada.

PDCI Market Access, a division of McKesson Canada Corporation
2300 Meadowvale Blvd.
Mississauga, ON L5N 5S1

Tel: 613-742-8225
Fax: 855-228-1549
E-mail: info@pdci.ca

If you are a Quebec resident and you have questions or comments about our efforts to protect your personal privacy, or if you require additional information about our privacy practices, please contact us at compliance@mckesson.ca. You may also write to our Privacy Officer at: McKesson Canada Corporation, Attn: Privacy Officer, 2300, Meadowvale Blvd., Mississauga, ON, L5N 5P9

© 2023 PDCI Market Access. All rights reserved.